227 related articles for article (PubMed ID: 23533593)
1. Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes.
Buglioni S; Di Filippo F; Terrenato I; Casini B; Gallo E; Marandino F; Maini CL; Pasqualoni R; Botti C; Di Filippo S; Pescarmona E; Mottolese M
PLoS One; 2013; 8(3):e58823. PubMed ID: 23533593
[TBL] [Abstract][Full Text] [Related]
2. Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.
Banerjee SM; Michalopoulos NV; Williams NR; Davidson T; El Sheikh S; McDermott N; Tran-Dang MA; Davison S; Keshtgar MR
Breast; 2014 Aug; 23(4):378-84. PubMed ID: 24630617
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis burden in sentinel nodes analysed using one-step nucleic acid amplification predicts axillary nodal status.
Milner TD; de Lusignan S; Jones S; Jackson PA; Layer GT; Kissin MW; Irvine TE
Breast; 2015 Oct; 24(5):568-75. PubMed ID: 26032111
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
Osako T; Iwase T; Kimura K; Horii R; Akiyama F
Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
[TBL] [Abstract][Full Text] [Related]
5. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.
Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z
Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008
[TBL] [Abstract][Full Text] [Related]
6. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
[TBL] [Abstract][Full Text] [Related]
7. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
[TBL] [Abstract][Full Text] [Related]
8. Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.
Vegué LB; Rojo F; Hardisson D; Iturriagagoitia AC; Panadés MJ; Velasco A; Bonet EL; Muñoz RC; Polo L;
Diagn Mol Pathol; 2012 Jun; 21(2):69-76. PubMed ID: 22555089
[TBL] [Abstract][Full Text] [Related]
9. Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
Martín-Sánchez E; Pernaut-Leza E; Mendaza S; Cordoba A; Vicente-Garcia F; Monreal-Santesteban I; Vizcaino JP; De Cerio MJ; Perez-Janices N; Blanco-Luquin I; Escors D; Ulazia-Garmendia A; Guerrero-Setas D
Virchows Arch; 2016 Jul; 469(1):51-9. PubMed ID: 27097811
[TBL] [Abstract][Full Text] [Related]
10. Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer.
Peña KB; Kepa A; Cochs A; Riu F; Parada D; Gumà J
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435629
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
Sagara Y; Ohi Y; Matsukata A; Yotsumoto D; Baba S; Tamada S; Sagara Y; Matsuyama Y; Ando M; Rai Y; Sagara Y
Breast Cancer; 2013 Apr; 20(2):181-6. PubMed ID: 22203582
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
Huxley N; Jones-Hughes T; Coelho H; Snowsill T; Cooper C; Meng Y; Hyde C; Mújica-Mota R
Health Technol Assess; 2015 Jan; 19(2):v-xxv, 1-215. PubMed ID: 25586547
[TBL] [Abstract][Full Text] [Related]
13. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
[TBL] [Abstract][Full Text] [Related]
14. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.
Visser M; Jiwa M; Horstman A; Brink AA; Pol RP; van Diest P; Snijders PJ; Meijer CJ
Int J Cancer; 2008 Jun; 122(11):2562-7. PubMed ID: 18324628
[TBL] [Abstract][Full Text] [Related]
15. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases.
Castellano I; Macrì L; Deambrogio C; Balmativola D; Bussone R; Ala A; Coluccia C; Sapino A
Ann Surg; 2012 Feb; 255(2):334-42. PubMed ID: 21975319
[TBL] [Abstract][Full Text] [Related]
16. Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer.
Ohi Y; Umekita Y; Sagara Y; Rai Y; Yotsumoto D; Matsukata A; Baba S; Tamada S; Matsuyama Y; Ando M; Sagara Y; Sasaki M; Tsuchimochi S; Tanimoto A; Sagara Y
Br J Cancer; 2012 Oct; 107(8):1239-43. PubMed ID: 22929881
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S
Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372
[TBL] [Abstract][Full Text] [Related]
18. A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.
Deambrogio C; Castellano I; Paganotti A; Zorini EO; Corsi F; Bussone R; Franchini R; Antona J; Miglio U; Sapino A; Antonacci C; Boldorini R
J Clin Pathol; 2014 Aug; 67(8):702-6. PubMed ID: 24906358
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology.
Pathmanathan N; Renthawa J; French JR; Edstrom-Elder E; Hall G; Mahajan H; Teh C; Bilous MA
ANZ J Surg; 2014 Oct; 84(10):730-4. PubMed ID: 24899463
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of sentinel lymph nodes in patients with breast cancer using one-step nucleic acid amplification (OSNA): Does not lead to overtreatment in the current era of de-escalating axillary management.
Hintzen KFH; de Rooij L; Schouten N; van Bastelaar J; Cörvers SAJ; Janssen A; van Haaren ERM; Vissers YLJ
Surg Oncol; 2020 Dec; 35():224-228. PubMed ID: 32932218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
